Study of the Medication GLE/PIB in Adult and Adolescent Participants With Acute Hepatitis C Virus Infection
Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!
Summary
- Eligibility
- for people ages 12 years and up (full criteria)
- Location
- at Sacramento, California and other locations
- Dates
- study startedcompletion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- Sponsor
- AbbVie
- Links
- This clinical study may be evaluating a usage that is not currently FDA approved. Please see US Prescribing Information for approved uses. Sign up for this study
- ID
- NCT04903626
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- About 286 people participating
- Last Updated